What You Should Know:
– Nucleus RadioPharma, the world’s first comprehensive radiopharmaceutical organization, today announced the closing of an extended Series A funding round with the addition of new investor AstraZeneca.
– The strategic investment bolsters…
Continue Reading
This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Several major fundraising announcements in the payer/employer space were announced in May….
Continue Reading
Oncology-focused digital therapeutics company Mika Health and global non-profit Cancer Support Community (CSC) announced the pair will provide an AI-enabled oncology-focused digital therapeutic for U.S.-based cancer patients and their caregivers to access mental health…
Continue Reading
By Shania Kennedy
June 03, 2024 – An AI tool developed by Mass General Brigham researchers has revealed that changes in muscle mass and fat quality over the course of immunotherapy are associated with poorer outcomes…
Continue Reading
Introduction to Paige’s Innovative Approach
Overview of Paige’s New Service Line
Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) applications has announced a groundbreaking new service line. This service is centered…
What You Should Know:
– Color Health, a leader in comprehensive cancer care, announced today that it is partnering with SkinIO and Bexa to integrate their innovative solutions for skin and breast cancer screening into…
Continue Reading
What You Should Know:
– PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
– …
Continue Reading
What You Should Know:
– OncoveryCare (formerly VivorCare) has closed an oversubscribed $4.5 million seed financing to launch its novel cancer survivorship care model.
– The fundraise was led by .406 Ventures alongside the McKay Institute…
Continue Reading
What You Should Know: – COTA, a leader in real-world data and analytics solutions, today announced a five-year extension of its research collaboration with the U.S. Food and Drug Administration’s (FDA) Oncology Center of…
Continue Reading
The following is a guest article by Dr. Daniel Vorobiof, Chief Medical Director at Belong.Life
The integration of artificial intelligence (AI) in oncology care has allowed for unprecedented levels of support and guidance for cancer…
